New developments in antidepressant therapy.
Depression is an overwhelmingly common problem in the United States. It is not only life threatening, but also costly, both personally and financially. Following a brief overview of depression, this article presents a variety of treatment modalities. Advantages and dis-advantages of each intervention are explored along with suggestions for evaluating current and future advances in treatment options.
Ward
Karen S
KS
School of Nursing, Box 81, Middle Tennessee State University, Murfreesboro, TN 37132, USA. kward@mtsu.edu
D000928:Antidepressive Agents / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use; D017281:Cost of Illness; D003866:Depressive Disorder / Q000175:diagnosis / Q000191:economics / Q000453:epidemiology / Q000628:therapy*; D004565:Electroconvulsive Therapy; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D018579:Patient Selection; D010789:Phototherapy; D008517:Phytotherapy; D011613:Psychotherapy; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology
D000928:Antidepressive Agents; D008996:Monoamine Oxidase Inhibitors; D017367:Selective Serotonin Reuptake Inhibitors